- Issuer ticker
-
BIIB
- Reported as of
-
30 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
02 Nov 2026, 17:37:00 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Bryan Keighery, attorney-in-fact for Dr. Grogan
Filing notes and source
Key filing fact
Jane Grogan filed Form 4 for BIOGEN INC. (BIIB) on 02 Nov 2026.
Key facts
- This page summarizes Jane Grogan's Form 4 filing for BIOGEN INC. (BIIB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Nov 2026, 17:37.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001995547
Primary reporting owner
Grogan Jane
- Relationship
-
Head of Research
- Address
- 225 BINNEY, CAMBRIDGE
- Signature
- /s/ Bryan Keighery, attorney-in-fact for Dr. Grogan
- Signature date
- 02 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +695
- Change %
- +17%
- Price
-
$0.000000*
- Shares after
- 4,753
- Date
- 30 Oct 2026
- Ownership
- Direct
BIIB
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -345
- Change %
- -7.3%
- Price
-
$253.62*
- Shares after
- 4,408
- Date
- 30 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIIB
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -695
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 30 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 695
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote
SEC remarks
Power of Attorney is attached hereto as Exhibit 24.